Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope for back pain after surgery: injections and needling put to the test

NCT ID NCT07555496

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 11, 2026 · Updated 1 time

Summary

This study will test two treatments for people with chronic low back pain who have already had spinal surgery. One treatment is an injection of a steroid and numbing medicine into the back muscles, and the other is dry needling (inserting thin needles into the same muscles). Both are done with ultrasound guidance. The goal is to see if these treatments can reduce pain and improve function, helping patients get more out of physical therapy. The study plans to enroll 120 participants.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
corticosteroid injection (Diprostene) and lidocaine
What this could lead to
If successful, this could provide a new, minimally invasive option to ease chronic back pain after spinal surgery and help patients better engage in rehabilitation.
What could go wrong
This is a small, early-stage study that has not yet started recruiting. The treatment involves steroids, which carry risks like infection or tissue damage, and the results may not apply to all back pain patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2026

Expected to finish

Mar 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient with chronic back pain, with previous surgery Exclusion Criteria: * Patients with specific or common low back pain * Patients receiving posterior subcutaneous spinal cord stimulation * Patients with a life expectancy of less than 12 months * Patients with a contraindication to corticosteroid injections (coagulation disorder) * Pregnant or breastfeeding patients * Patients with cognitive and/or psychobehavioral disorders

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Back pain lower back chronic are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Emerald Coast Clinic

    RECRUITING

    St-Malo, 35400, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.